IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Andreas Bommarius

USPTO Granted Patents = 23

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 150(Granted Patents)


Location History:

  • Frankfurt/M, DE (1997 - 2003)
  • Frankfurt-am-Main, DE (1994 - 2008)

Company Filing History:

goldMedal18 out of 1,678 
 
Degussa Aktiengesellschaft
 patents
silverMedal1 out of 204 
 
Forschungszentrum Juelich Gmbh
 patents
bronzeMedal1 out of 4,547 
 
California Institute of Technology
 patents
4. 1 out of 145 
 
Degussa - Huls Ag
 patents
5. 1 out of 4 
 
University of Stuttgart
 patents
6. 1 out of 2 
 
Degussa Aktiengesellchaft
 patents
7. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2008

Loading Chart...
23 patents (USPTO):
1. 7393679 - Whole cell catalyst (2008-07-01),
2. 6713288 - Whole cell catalysts (2004-03-30),
3. 6524837 - Hydantoinase variants with improved properties and their use for the production of amino acids (2003-02-25),
4. 6472571 - Process for the production of organic compounds in a membrane reactor (2002-10-29),
5. 6372459 - N-acetyl amino acid racemase (2002-04-16),
6. 6333176 - Process for obtaining microorganisms containing peptide amidase, microorganisms obtained therewith, peptide amidases contained in them and use thereof (2001-12-25),
7. 6326327 - Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use (2001-12-04),
8. 6251625 - Process for preparing peptides and N-carbamoyl-protected peptides (2001-06-26),
9. 6180837 - Process for the catalytic enantioselective reduction of ketones (2001-01-30),
10. 6180551 - Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use (2001-01-30),
11. 6114163 - Process for obtaining active L-.alpha.-amino carboxylic acids from (2000-09-05),
12. 6080887 - Process for racemization of N-acetyl-(D)L-.alpha.-amino carboxylic acids (2000-06-27),
13. 5985632 - Peptide amidase from xanthomonas (1999-11-16),
14. 5827717 - Microorganisms their use and method of producing L-.alpha.-amino acids (1998-10-27),
15. 5714355 - Microorganism, use thereof and process for the production of (1998-02-03),

Title: Innovations of Andreas Bommarius in Biocatalysis

Introduction

Andreas Bommarius, based in Frankfurt am Main, Germany, is a prominent inventor known for his significant contributions to the field of biocatalysis. With an impressive portfolio of 23 patents, Bommarius has been a pioneer in developing innovative catalysts that facilitate the production of amino acids from hydantoins.

Latest Patents

Bommarius's latest patents include a novel whole cell catalyst comprising a hydantoinase, a racemase, and a carbamoylase. This innovative catalyst efficiently degrades hydantoins into amino acids. Additionally, he has claimed a process for the production of these catalysts and a method for synthesizing amino acids. Another key patent describes a transformed microorganism that incorporates DNA sequences encoding the same enzymes, allowing the microorganism to directly convert hydantoins into amino acids. This breakthrough includes processes for producing both the microorganism and amino acids using the organism.

Career Highlights

Throughout his career, Bommarius has been associated with reputable companies, including Degussa Aktiengesellschaft. His work has focused on improving biocatalytic processes, which hold great potential for various industrial applications.

Collaborations

Bommarius has collaborated with esteemed coworkers such as Karlheinz Drauz and Hans-Dieter Jakubke. These collaborations have further enhanced the development and application of his innovative biocatalysts.

Conclusion

Andreas Bommarius continues to be a significant figure in the realm of biocatalysis. His inventive approach to developing whole cell catalysts and processes for amino acid production marks him as a key inventor in his field. His body of work not only showcases his dedication to innovation but also highlights the impact of his inventions on the biotechnological landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…